{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:59:21Z","timestamp":1772762361946,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jpurol.2016.04.023","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T23:05:47Z","timestamp":1464131147000},"page":"219.e1-219.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combined low-dose antimuscarinics for refractory detrusor overactivity in children"],"prefix":"10.1016","volume":"12","author":[{"given":"A.","family":"Fahmy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Youssif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rhashad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Mokhless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2016.04.023_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(03)00622-7","article-title":"Antimuscarinics for the treatment of overactive bladder","volume":"3","author":"Andersson","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpurol.2016.04.023_bib2","first-page":"291","article-title":"Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan","volume":"14","author":"D'Souza","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jpurol.2016.04.023_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00120-006-1096-5","article-title":"Oral anticholinergics in overactive bladder","volume":"45","author":"Madersbacher","year":"2006","journal-title":"Urologe A"},{"key":"10.1016\/j.jpurol.2016.04.023_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","article-title":"Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder","volume":"57","author":"Van Kerrebroeck","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2016.04.023_bib5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3949\/ccjm.69.10.761","article-title":"The newer antimuscarinic drugs: bladder control with less dry mouth","volume":"69","author":"Appell","year":"2002","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"10.1016\/j.jpurol.2016.04.023_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-5347(06)00305-3","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society (ICCS)","volume":"176","author":"Nev\u00e9us","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2016.04.023_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1464-410X.2001.00084.x","article-title":"The overactive bladder in children: a potential future indication for tolterodine","volume":"87","author":"Hjalmas","year":"2001","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.jpurol.2016.04.023_bib8","first-page":"27","article-title":"Adverse effects of oxybutynin chloride in pediatrics","volume":"50","author":"Jonville","year":"1993","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.jpurol.2016.04.023_bib9","series-title":"Incontinence. Proceedings of the 1st International Consultation on incontinence; Monaco, June 28\u2013July 1 1998","year":"1999"},{"key":"10.1016\/j.jpurol.2016.04.023_bib10","doi-asserted-by":"crossref","first-page":"E88","DOI":"10.5489\/cuaj.269","article-title":"Efficacy and tolerability of combined medication of two different antimuscarinics for treatment of adults with idiopathic overactive bladder","volume":"7","author":"Yi","year":"2013","journal-title":"Can Urol Assoc J"},{"issue":"5","key":"10.1016\/j.jpurol.2016.04.023_bib11","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1097\/01.ju.0000085667.05190.ad","article-title":"Trospium chloride for the treatment of detrusor instability in children","volume":"170","author":"Lopez Pereira","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2016.04.023_bib12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.eururo.2008.01.007","article-title":"Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects","volume":"53","author":"Amend","year":"2008","journal-title":"Eur Urol"},{"issue":"Suppl. 4","key":"10.1016\/j.jpurol.2016.04.023_bib13","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.juro.2009.05.099","article-title":"Double anticholinergic therapy for refractory overactive bladder","volume":"182","author":"Bolduc","year":"2009","journal-title":"J Urol"},{"issue":"Suppl. 2","key":"10.1016\/j.jpurol.2016.04.023_bib14","first-page":"S80","article-title":"Muscarinic receptors in the bladder: from basic research to therapeutics","volume":"147","author":"Hegde","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpurol.2016.04.023_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0302-2838(02)00540-7","article-title":"Antimuscarinics and the overactive detrusor\u2013which is the main mechanism of action?","volume":"43","author":"Andersson","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2016.04.023_bib16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1464-410X.2007.06866.x","article-title":"Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity","volume":"99","author":"Mansfield","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2016.04.023_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/nau.20796","article-title":"Antimuscarinics and overactive bladder: other mechanism of action","volume":"29","author":"Yamaguchi","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2016.04.023_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/nau.20208","article-title":"Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics","volume":"25","author":"De Laet","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2016.04.023_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.eururo.2007.02.057","article-title":"Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve","volume":"52","author":"Iijima","year":"2007","journal-title":"Eur Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513116300511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513116300511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:41:21Z","timestamp":1761486081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513116300511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1477513116300511"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2016.04.023","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined low-dose antimuscarinics for refractory detrusor overactivity in children","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2016.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}